GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SeaStar Medical Holding Corp (NAS:ICU) » Definitions » EPS (Diluted)

SeaStar Medical Holding (SeaStar Medical Holding) EPS (Diluted) : $-1.23 (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is SeaStar Medical Holding EPS (Diluted)?

SeaStar Medical Holding's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $-0.21. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.23.

SeaStar Medical Holding's EPS (Basic) for the three months ended in Dec. 2023 was $-0.21. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.23.

SeaStar Medical Holding's EPS without NRI for the three months ended in Dec. 2023 was $-0.17. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.98.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


SeaStar Medical Holding EPS (Diluted) Historical Data

The historical data trend for SeaStar Medical Holding's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SeaStar Medical Holding EPS (Diluted) Chart

SeaStar Medical Holding Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
-0.26 -0.36 -1.48 -1.21

SeaStar Medical Holding Quarterly Data
Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.66 -0.40 -0.25 -0.37 -0.21

Competitive Comparison of SeaStar Medical Holding's EPS (Diluted)

For the Biotechnology subindustry, SeaStar Medical Holding's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SeaStar Medical Holding's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SeaStar Medical Holding's PE Ratio distribution charts can be found below:

* The bar in red indicates where SeaStar Medical Holding's PE Ratio falls into.



SeaStar Medical Holding EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

SeaStar Medical Holding's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-26.232-0)/21.670
=-1.21

SeaStar Medical Holding's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-9.875-0)/47.615
=-0.21

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SeaStar Medical Holding  (NAS:ICU) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


SeaStar Medical Holding EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of SeaStar Medical Holding's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


SeaStar Medical Holding (SeaStar Medical Holding) Business Description

Traded in Other Exchanges
N/A
Address
3513 Brighton Boulevard, Suite 410, Denver, CO, USA, 80216
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
Executives
Heel Kenneth Van director C/O PFENEX INC., 10790 ROSELLE STREET, SAN DIEGO CA 92121
Kevin Chung officer: Chief Medical Officer C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Richard D. Russell director 3201 W BAY VISTA AVE, TAMPA FL 33611
Bruce M. Rodgers director 302 KNIGHTS RUN AVE., STE. 1000, TAMPA FL 33602
Andres Lobo director C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Caryl Baron officer: See Remarks C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Eric Schlorff director, officer: Chief Executive Officer C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Rick Barnett director C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Allan Collins director C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Dow Employees' Pension Plan Trust 10 percent owner 2211 H.H. DOW WAY, SSC BUILDING, MIDLAND MI 48674
Union Carbide Employees' Pension Plan Trust 10 percent owner 2211 H.H. DOW WAY, SSC BUILDING, MIDLAND MI 48674
Martin A Traber director 100 N TAMPA STREET, SUITE 2700, TAMPA FL 33602
Lm Funding America, Inc. 10 percent owner 1200 WEST PLATT STREET, SUITE 100, TAMPA FL 33606
Craig E Burson director 400 N. PARK AVENUE, UNIT 10B, BRECKENRIDGE CO 80424
Bruce H Bennett director 3929 ARLINGTON DRIVE, PALM HARBOR FL 34685

SeaStar Medical Holding (SeaStar Medical Holding) Headlines

From GuruFocus